Why the study?
In alveolar rhabdomyosarcoma, PAX3-FOXO1 is linked to poor prognosis and B7-H3 is linked to cancer aggressiveness, but the relationship between them and the biological roles of B7-H3 in ARMS were unknown.
PAX3-FOXO1 regulates B7-H3 expression, and both are associated with cell migration and myogenic differentiation block in alveolar rhabdomyosarcoma.
Hypothesis-generating for B7-H3 targeting in alveolar rhabdomyosarcoma; leaves open clinical translation pending further validation.
B7-H3 (also known as CD276) is associated with aggressive characteristics in various cancers. Meanwhile, in alveolar rhabdomyosarcoma (ARMS), PAX3-FOXO1 fusion protein is associated with increased aggressiveness and poor prognosis. In the present study, we explored the relationship between PAX3-FOXO1 and B7-H3 and the biological roles of B7-H3 in ARMS. Quantitative real time PCR and flow cytometry revealed that PAX3-FOXO1 knockdown downregulated B7-H3 expression in all the selected cell lines (Rh-30, Rh-41, and Rh-28), suggesting that PAX3-FOXO1 positively regulates B7-H3 expression. Gene expression analysis revealed that various genes and pathways involved in chemotaxis, INF-γ production, and myogenic differentiation were commonly affected by the knockdown of PAX3-FOXO1 and B7-H3. Wound healing and transwell migration assays revealed that both PAX3-FOXO1 and B7-H3 were associated with cell migration. Furthermore, knockdown of PAX3-FOXO1 or B7-H3 induced myogenin expression in all cell lines, although myosin heavy chain induction varied depending on the cellular context. Our results indicate that PAX3-FOXO1 regulates B7-H3 expression and that PAX3-FOXO1 and B7-H3 are commonly associated with multiple pathways related to an aggressive phenotype in ARMS, such as cell migration and myogenic differentiation block.
No takes yet. Share an insight, caveat, or question.
Kanayama et al. (2021) studied this question.